新冠病毒（SARS-CoV-2）感染发生在完全接种疫苗很长时间后，与中和抗体缺乏有关。
SARS-CoV-2 infection long time after full vaccination is related to a lack of neutralizing antibodies.
机构信息
Univ Lille, Faculté de Médecine, CHU Lille, Laboratoire de Virologie ULR3610, Lille, France.
Univ Lille, Faculté de Médecine, CHU Lille, Institut de Microbiologie, F-59000 Lille France.
出版信息
Diagn Microbiol Infect Dis. 2022 Jan;102(1):115565. doi: 10.1016/j.diagmicrobio.2021.115565. Epub 2021 Oct 2.
Abstract
SARS-CoV-2 infections after COVID-19 vaccination are not unexpected, but those occurring more than 14 days after second vaccine dose need to be investigated. We describe a well-characterized infection which occurred almost 2 months after full vaccination, and provide the evidence of a link with a lack of anti-SARS-CoV-2 neutralizing antibodies.
摘要
接种 COVID-19 疫苗后感染 SARS-CoV-2 并不意外，但第二剂疫苗接种后超过 14 天发生的感染需要调查。我们描述了一起特征明确的感染事件，该事件发生在完全接种疫苗近 2 个月后，并提供了与缺乏抗 SARS-CoV-2 中和抗体有关的证据。
相似文献
1
SARS-CoV-2 infection long time after full vaccination is related to a lack of neutralizing antibodies.新冠病毒（SARS-CoV-2）感染发生在完全接种疫苗很长时间后，与中和抗体缺乏有关。
Diagn Microbiol Infect Dis. 2022 Jan;102(1):115565. doi: 10.1016/j.diagmicrobio.2021.115565. Epub 2021 Oct 2.
2
Immunogenicity of COVID-19 Tozinameran Vaccination in Patients on Chronic Dialysis.慢性透析患者 COVID-19 疫苗接种的免疫原性。
Front Immunol. 2021 Jun 30;12:690698. doi: 10.3389/fimmu.2021.690698. eCollection 2021.
3
Induction of High Levels of Specific Humoral and Cellular Responses to SARS-CoV-2 After the Administration of Covid-19 mRNA Vaccines Requires Several Days.接种 COVID-19 mRNA 疫苗后，需要数天才能诱导针对 SARS-CoV-2 的高特异性体液和细胞反应。
Front Immunol. 2021 Oct 4;12:726960. doi: 10.3389/fimmu.2021.726960. eCollection 2021.
4
Evolution of antibody responses up to 13 months after SARS-CoV-2 infection and risk of reinfection.新型冠状病毒感染后长达13个月的抗体反应演变及再次感染风险。
EBioMedicine. 2021 Sep;71:103561. doi: 10.1016/j.ebiom.2021.103561. Epub 2021 Aug 27.
5
Immunogenicity after two doses of inactivated virus vaccine in healthcare workers with and without previous COVID-19 infection: Prospective observational study.医护人员接种两剂灭活病毒疫苗后的免疫原性：有和无既往 COVID-19 感染的前瞻性观察研究。
J Med Virol. 2022 Jan;94(1):279-286. doi: 10.1002/jmv.27316. Epub 2021 Sep 10.
6
BNT162b2 COVID-19 vaccine and correlates of humoral immune responses and dynamics: a prospective, single-centre, longitudinal cohort study in health-care workers.BNT162b2 新冠病毒疫苗与体液免疫应答及动力学的相关性：医护人员前瞻性、单中心、纵向队列研究。
Lancet Respir Med. 2021 Sep;9(9):999-1009. doi: 10.1016/S2213-2600(21)00220-4. Epub 2021 Jul 2.
7
Antibody response elicited by a third boost dose of inactivated SARS-CoV-2 vaccine can neutralize SARS-CoV-2 variants of concern.灭活新冠病毒疫苗第三次加强剂量引发的抗体反应可中和新冠病毒变异株。
Emerg Microbes Infect. 2021 Dec;10(1):2125-2127. doi: 10.1080/22221751.2021.1996210.
8
SARS-CoV-2 Variant Antibodies Wane 6 Months After Vaccination.接种疫苗6个月后，针对新冠病毒变异株的抗体水平下降。
JAMA. 2021 Sep 14;326(10):901. doi: 10.1001/jama.2021.15115.
9
Robust Neutralizing Antibody Levels Detected after Either SARS-CoV-2 Vaccination or One Year after Infection.接种 SARS-CoV-2 疫苗或感染一年后均可检测到强大的中和抗体水平。
Viruses. 2021 Oct 5;13(10):2003. doi: 10.3390/v13102003.
10
SARS-CoV-2 immunogenicity in individuals infected before and after COVID-19 vaccination: Israel, January-March 2021.2021 年 1 月至 3 月期间，在以色列，新冠病毒疫苗接种前后感染 SARS-CoV-2 的个体的免疫原性。
Epidemiol Infect. 2021 Aug 17;149:e239. doi: 10.1017/S0950268821001928.
引用本文的文献
1
Discordant Humoral and T-Cell Response to mRNA SARS-CoV-2 Vaccine and the Risk of Breakthrough Infections in Women with Breast Cancer, Receiving Cyclin-Dependent Kinase 4 and 6 Inhibitors.乳腺癌女性接受细胞周期蛋白依赖性激酶4和6抑制剂治疗时，对mRNA SARS-CoV-2疫苗的体液和T细胞反应不一致及突破性感染风险
Cancers (Basel). 2023 Mar 27;15(7):2000. doi: 10.3390/cancers15072000.
2
Longevity of immunity following COVID-19 vaccination: a comprehensive review of the currently approved vaccines.新冠病毒疫苗接种后的免疫持久性：目前批准疫苗的综合评价。
Hum Vaccin Immunother. 2022 Nov 30;18(5):2037384. doi: 10.1080/21645515.2022.2037384. Epub 2022 Apr 13.
Zotero 插件